List view / Grid view
26 July 2013 | By Virgo Health
“The number of people at risk from complications associated with type 2 diabetes continues to rise..."
25 July 2013 | By AstraZeneca
The US FDA has acknowledged receipt of the NDA resubmission for investigational drug dapagliflozin for the treatment of adults with type 2 diabetes...
25 July 2013 | By Abbott
Abbott has received U.S. FDA clearance for its FreeStyle Precision Pro Blood Glucose and β-Ketone Monitoring System™...
25 July 2013 | By AstraZeneca
NDA for dapagliflozin resubmitted to FDA...
25 July 2013 | By Sanofi
Combined diabetes and obesity, ‘diabesity’, is a serious health problem...
24 July 2013 | By Novartis
Following JCVI interim recommendation on Novartis Bexsero® vaccine...
24 July 2013 | By Merck
Merck announced that the NDA for vorapaxar, has been accepted for standard review...
24 July 2013 | By Roche
Results from the phase III CLL11 study...
23 July 2013 | By Bristol-Myers Squibb Company
Joint effort supports early disease identification to connect at-risk patients to necessary care...
23 July 2013 | By SOTAX AG
SPS Pharma Services, a worldwide leader for dissolution method development has moved to its new site in Orleans, France...
22 July 2013 | By Roche
Roche invites 100 students from all over Europe to the Salzburg Festival...
22 July 2013 | By IChemE
The Institution of Chemical Engineers has announced The Apprentice’s Nick Hewer to host IChemE Awards...
19 July 2013 | By Biogen Idec
U.S. and EU regulatory authorities have accepted marketing applications...
19 July 2013 | By Roche
Tests support long-term routine management of organ transplant recipients...
18 July 2013 | By Roche
Roche announced the global launch of Elecsys ProGRP...
